Literature DB >> 3364150

Clinical experience of long-term treatment with epidural and intrathecal opioids--a nationwide survey.

S Arnér1, N Rawal, L L Gustafsson.   

Abstract

Long-term use of spinal opioids to treat chronic severe pain is widely established. However, the indications, shortcomings and complications of the method have not been completely described. Experience with spinal opioids was analysed for the period 1979-1984 in a nationwide Swedish survey. Out of 93 anaesthesia departments, 69 used the method. Approximately 750 patients were treated with epidural morphine for an average duration of 124 days (3-450). Eighteen patients were treated with intrathecal morphine for an average period for 47 days (3-90). The intrathecal approach was used in all clinics because of failure of the epidural route. In only one department was the intrathecal approach used as the primary route of therapy, depending on the mechanism of pain. The highest daily morphine dose was 480 mg and 50 mg for epidural and intrathecal routes, respectively. The patients given the highest dosages were not necessarily those subjected to the longest treatment. The need for increased dosage seems to be related not only to changes in receptor sensitivity but also to changes in pain mechanisms. No case of threatening ventilatory depression was reported. Thirty-two departments had treated a few patients with chronic non-cancer pain conditions. Initial results were considered "excellent" in 11 departments, but at follow-up results were excellent in only one department. In addition to dislocation, occlusion of the catheters or leakage, injection pain was an obstacle to successful treatment. Pruritus urinary retention, and local infections were not reported as significant problems, but one case of meningitis was reported.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3364150     DOI: 10.1111/j.1399-6576.1988.tb02725.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  36 in total

1.  Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance.

Authors:  T W Vanderah; N M Suenaga; M H Ossipov; T P Malan; J Lai; F Porreca
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process.

Authors:  E Célèrier; J P Laulin; J B Corcuff; M Le Moal; G Simonnet
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 3.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

4.  CXCR4 signaling mediates morphine-induced tactile hyperalgesia.

Authors:  Natalie M Wilson; Hosung Jung; Matthew S Ripsch; Richard J Miller; Fletcher A White
Journal:  Brain Behav Immun       Date:  2010-12-28       Impact factor: 7.217

5.  Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila Keresztes; Jiyang Ren; William R Roeske; Todd W Vanderah; Eva V Varga
Journal:  J Neuroimmunol       Date:  2012-01-30       Impact factor: 3.478

Review 6.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  A successful case in cancer pain management with high-dose intravenous morphine.

Authors:  T Ishikawa; K Hiraga
Journal:  J Anesth       Date:  1995-12       Impact factor: 2.078

8.  NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice.

Authors:  T Doyle; E Esposito; L Bryant; S Cuzzocrea; D Salvemini
Journal:  Neuroscience       Date:  2013-02-27       Impact factor: 3.590

9.  Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance.

Authors:  T Doyle; L Bryant; I Batinic-Haberle; J Little; S Cuzzocrea; E Masini; I Spasojevic; D Salvemini
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

10.  Opiate-induced hypernociception and chemokine receptors.

Authors:  Fletcher White; Natalie Wilson
Journal:  Neuropharmacology       Date:  2009-07-15       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.